We believe that evaluations of the translational values of blocking Drp1 should extend beyond in vitro mitochondrial morphology and function, and that it should be conducted in mammalian animal models with brain pathologies and motor impairment as seen in PD. The gene discussed is DNM1L; the disease is Parkinson disease.